Brian Piekos, Chief Financial Officer at Gemini Therapeutics, Inc. /DE (GMTX), bought 15,310 shares at $9.46 ($145K) on 2021-05-14, disclosed to the SEC on 2021-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.46 | 7,655 | $72K | 50.0% |
| 2 | $9.46 | 7,655 | $72K | 50.0% |
| Total | $9.46 avg | 15,310 | $145K | 100% |
| Filing → |
| KALV | SELL | 2026-02-24 | $55K | — | Filing → |
| KALV | SELL | 2025-11-26 | $120K | — | Filing → |